The Department of Health and Human Services announced that as part of the agency’s tackling of the “autism epidemic,” it planned to greenlight a change to the language on acetaminophen (the active ingredient in Tylenol) bottles that warns pregnant people of an increased risk of neurological conditions in babies, like autism and ADHD, if taken during pregnancy.
It plans to approve health insurance coverage for a medication called leucovorin as a treatment for autism spectrum disorder. Many scientists and providers are skeptical.
The proposal comes as HHS explores “a potential association between acetaminophen use during pregnancy and adverse neurodevelopmental outcomes.”
– Sofi Gratas | GPB Via Rough Draft
